170 related articles for article (PubMed ID: 28844506)
1. [Stereotactic body radiation therapy for hepatic malignancies: Organs at risk, uncertainties margins, doses].
Lacornerie T; Rio E; Mahé MA
Cancer Radiother; 2017 Oct; 21(6-7):574-579. PubMed ID: 28844506
[TBL] [Abstract][Full Text] [Related]
2. [Doses to organs at risk in conformational and stereotactic body radiation therapy: Liver].
Debbi K; Janoray G; Scher N; Deutsch É; Mornex F
Cancer Radiother; 2017 Oct; 21(6-7):604-612. PubMed ID: 28893525
[TBL] [Abstract][Full Text] [Related]
3. [Delineation of organs at risk and dose constraints].
Noël G; Antoni D; Barillot I; Chauvet B
Cancer Radiother; 2016 Sep; 20 Suppl():S36-60. PubMed ID: 27516050
[TBL] [Abstract][Full Text] [Related]
4. [Stereotactic body radiation therapy in the management of liver tumours].
Jacob J; Nguyen F; Deutsch E; Mornex F
Cancer Radiother; 2014 Oct; 18(5-6):486-94. PubMed ID: 25195113
[TBL] [Abstract][Full Text] [Related]
5. [Hepatic tumors and radiotherapy].
Rio E; Mornex F; Peiffert D; Huertas A
Cancer Radiother; 2016 Sep; 20 Suppl():S174-8. PubMed ID: 27521035
[TBL] [Abstract][Full Text] [Related]
6. Hepatic tumours and radiotherapy.
Rio E; Mornex F; Maingon P; Peiffert D; Parent L
Cancer Radiother; 2022; 26(1-2):266-271. PubMed ID: 34953707
[TBL] [Abstract][Full Text] [Related]
7. [Stereotactic body radiotherapy. How to better protect normal tissues?].
Pasquier D; Lacornerie T; Mirabel X; Brassart C; Vanquin L; Lartigau E
Cancer Radiother; 2019 Oct; 23(6-7):630-635. PubMed ID: 31447339
[TBL] [Abstract][Full Text] [Related]
8. [Liver stereotactic body radiotherapy: Clinical features and technical consequences, results. Which treatment machine in which situation?].
Riou O; Valdenaire S; Debuire P; Fenoglietto P; Debrigode C; Mazard T; Assenat É; Aillères N; Azria D
Cancer Radiother; 2019 Oct; 23(6-7):636-650. PubMed ID: 31444078
[TBL] [Abstract][Full Text] [Related]
9. [Which constraints for which organs at risk in radiotherapy for adult patients?].
Antoni D; Noël G
Cancer Radiother; 2015 Oct; 19(6-7):479-83. PubMed ID: 26282215
[TBL] [Abstract][Full Text] [Related]
10. [Doses to organs at risk for conformational and stereotactic radiotherapy: Bladder].
Duvergé L; Castelli J; Lizée T; de Crevoisier R; Azria D
Cancer Radiother; 2017 Oct; 21(6-7):597-603. PubMed ID: 28882511
[TBL] [Abstract][Full Text] [Related]
11. [Dose constraints to organs at risk for conformational and stereotactic radiotherapy: Small bowel and duodenum].
Goupy F; Chajon E; Castelli J; Le Prisé É; Duvergé L; Jaksic N; Vogin G; Monpetit É; Klein V; de Bosschère L; Maingon P
Cancer Radiother; 2017 Oct; 21(6-7):613-618. PubMed ID: 28886980
[TBL] [Abstract][Full Text] [Related]
12. [Radiotherapy for intrathoracic metastases].
Giraud P; Lacornerie T; Mornex F
Cancer Radiother; 2016 Sep; 20 Suppl():S157-60. PubMed ID: 27523413
[TBL] [Abstract][Full Text] [Related]
13. [An analysis of 20 consecutive patients treated with stereotactic body radiotherapy on Novalis Tx(®) for stage I non-small-cell lung cancer].
Guillerme F; Clavier JB; Schumacher C; Falcoz PE; Bourrhala K; Santelmo N; Hassler S; Schott R; Quoix E; Massard G; Noël G
Cancer Radiother; 2013; 17(4):272-81. PubMed ID: 23712043
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous integrated protection : A new concept for high-precision radiation therapy.
Brunner TB; Nestle U; Adebahr S; Gkika E; Wiehle R; Baltas D; Grosu AL
Strahlenther Onkol; 2016 Dec; 192(12):886-894. PubMed ID: 27757502
[TBL] [Abstract][Full Text] [Related]
15. [Lung dose constraints for normo-fractionated radiotherapy and for stereotactic body radiation therapy].
Blais E; Pichon B; Mampuya A; Antoine M; Lagarde P; Kantor G; Breton-Callu C; Lefebvre C; Gerard M; Aamarcha A; Ozsahin M; Bourhis J; Maingon P; Troussier I; Pourel N
Cancer Radiother; 2017 Oct; 21(6-7):584-596. PubMed ID: 28886981
[TBL] [Abstract][Full Text] [Related]
16. [Hippocampus, brainstem and brain dose-volume constraints for fractionated 3-D radiotherapy and for stereotactic radiation therapy: Limits and perspectives].
Gérard M; Jumeau R; Pichon B; Biau J; Blais E; Horion J; Noël G
Cancer Radiother; 2017 Oct; 21(6-7):636-647. PubMed ID: 28893524
[TBL] [Abstract][Full Text] [Related]
17. Management and work-up procedures of patients with head and neck malignancies treated by radiation.
Grégoire V; Boisbouvier S; Giraud P; Maingon P; Pointreau Y; Vieillevigne L
Cancer Radiother; 2022; 26(1-2):147-155. PubMed ID: 34953696
[TBL] [Abstract][Full Text] [Related]
18. [Tolerance of hypofractionated stereotactic radiotherapy for hepatic tumours].
Le Bon M; Lapeyre M; Moreau J; Bellière-Calandry A; Pezet D; Abergel A; Bellini R; Kwiatkowski F; Verrelle P; Martin F; Benoît C
Cancer Radiother; 2019 Sep; 23(5):385-394. PubMed ID: 31300328
[TBL] [Abstract][Full Text] [Related]
19. [Doses to organs at risk in conformational radiotherapy and stereotaxic irradiation: The heart].
Vandendorpe B; Servagi Vernat S; Ramiandrisoa F; Bazire L; Kirova YM
Cancer Radiother; 2017 Oct; 21(6-7):626-635. PubMed ID: 28867460
[TBL] [Abstract][Full Text] [Related]
20. 4π noncoplanar stereotactic body radiation therapy for centrally located or larger lung tumors.
Dong P; Lee P; Ruan D; Long T; Romeijn E; Low DA; Kupelian P; Abraham J; Yang Y; Sheng K
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):407-13. PubMed ID: 23523322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
